The ABCG family of membrane-associated transporters: You don't have to be big to be mighty

British Journal of Pharmacology

Volumn 164, Issue 7, 2011, Pages 1767-1779

  Kerr, Ian D ^a   Haider, Ameena J ^a   Gelissen, Ingrid C ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

ABC transporter; ABCG1; ABCG2; ABCG5; ABCG8; cancer multidrug resistance; lipid transport

Indexed keywords

ABACAVIR; ABC TRANSPORTER; ABC TRANSPORTER G; ABC TRANSPORTER G1; ABC TRANSPORTER G4; ABC TRANSPORTER G5; ABC TRANSPORTER G8; ANACETRAPIB; ANTINEOPLASTIC AGENT; APIGENIN; BIOCHANIN A; BREAST CANCER RESISTANCE PROTEIN; CIPROFLOXACIN; CYCLOSPORIN A; DALCETRAPIB; DAUNORUBICIN; DOXORUBICIN; ELACRIDAR; ERLOTINIB; ETOPOSIDE; GEFITINIB; METHOTREXATE; MITOXANTRONE; NELFINAVIR; PRAZOSIN; TACROLIMUS; TELMISARTAN; TOPOTECAN; TORCETRAPIB; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ATHEROSCLEROSIS; BINDING AFFINITY; CARCINOMA; CELLULAR DISTRIBUTION; CHOLESTEROL TRANSPORT; DRUG ABSORPTION; DRUG BINDING SITE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG EXCRETION; DRUG METABOLISM; DRUG POTENCY; DRUG TARGETING; DRUG TRANSPORT; ENZYME SPECIFICITY; HUMAN; IC 50; MEMBRANE TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REVIEW; TISSUE DISTRIBUTION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION; HUMANS; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; TISSUE DISTRIBUTION;

EID: 80053436675     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.01177.x     Document Type: Review

References (108)

1. Ahmed-Belkacem A, Pozza A, Munoz-Martinez F, Bates SE, Castanys S, Gamarro F, et al,. (2005). Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2. Cancer Res 65: 4852-4860. (Pubitemid 40740824)
2. Allen JD, van Loevezijn A, Lakhai JM, van der Valk M, van Tellingen O, Reid G, et al,. (2002). Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol Cancer Ther 1: 417-425.
3. Armstrong AJ, Gebre AK, Parks JS, Hedrick CC, (2010). ATP-binding cassette transporter G1 negatively regulates thymocyte and peripheral lymphocyte proliferation. J Immunol 184: 173-183.
4. Aulchenko YS, Ripatti S, Lindqvist I, Boomsma D, Heid IM, Pramstaller PP, et al,. (2009). Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 41: 47-55.
5. Bailey-Dell KJ, Hassel B, Doyle LA, Ross DD, (2001). Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene. Biochim Biophys Acta 1520: 234-241. (Pubitemid 32868794)
6. Barter P, (2009). Lessons learned from the Investigation of Lipid Level Management to Understand its Impact in Atherosclerosis Events (ILLUMINATE) trial. Am J Cardiol 104: 10E-15E.
7. Benderra Z, Faussat AM, Sayada L, Perrot JY, Chaoui D, Marie JP, et al,. (2004). Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias. Clin Cancer Res 10: 7896-7902. (Pubitemid 39587528)
8. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, et al,. (2000). Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290: 1771-1775. (Pubitemid 32004809)
9. Bhatia A, Schafer HJ, Hrycyna CA, (2005). Oligomerization of the Human ABC Transporter ABCG2: evaluation of the Native Protein and Chimeric Dimers. Biochemistry 44: 10893-10904. (Pubitemid 41153650)
10. Bhattacharya AK, Connor JE, (1974). b-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters. J Clin Invest 53: 1033-1043.
11. Calpe-Berdiel L, Rotllan N, Fievet C, Roig R, Blanco-Vaca F, Escola-Gil JC, (2008). Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8. J Lipid Res 49: 1904-1911.
12. Chen H, Rossier C, Lalioti MD, Lynn A, Chakravarti A, Perrin G, et al,. (1996). Cloning of the cDNA for a human homologue of the Drosophila white gene and mapping to chromosome 21q22.3. Am J Hum Genet 59: 66-75. (Pubitemid 26189730)
13. Clark R, Kerr ID, Callaghan R, (2006). Multiple drugbinding sites on the R482G isoform of the ABCG2 transporter. Br J Pharmacol 149: 506-515. (Pubitemid 44658511)
14. Cserepes J, Szentpetery Z, Seres L, Ozvegy-Laczka C, Langmann T, Schmitz G, et al,. (2004). Functional expression and characterization of the human ABCG1 and ABCG4 proteins: indications for heterodimerization. Biochem Biophys Res Commun 320: 860-867. (Pubitemid 38887222)
15. Cuchel M, Lund-Katz S, Llera-Moya M, Millar JS, Chang D, Fuki I, et al,. (2010). Pathways by which reconstituted high-density lipoprotein mobilizes free cholesterol from whole body and from macrophages. Arterioscler Thromb Vasc Biol 30: 526-532.
16. Damiani D, Tiribelli M, Michelutti A, Geromin A, Cavallin M, Fabbro D, et al,. (2010). Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients. Leuk Res 34: 942-945.
17. Dehghan A, Kottgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F, et al,. (2008). Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 372: 1953-1961.
18. Diop NK, Hrycyna CA, (2005). N-Linked glycosylation of the human ABC transporter ABCG2 on asparagine 596 is not essential for expression, transport activity, or trafficking to the plasma membrane. Biochemistry 44: 5420-5429. (Pubitemid 40489981)
19. Dohse M, Scharenberg C, Shukla S, Robey RW, Volkmann T, Deeken JF, et al,. (2010). Comparison of ATP-binding cassette transporter interactions with the tyrosine kinase inhibitors imatinib, nilotinib, and dasatinib. Drug Metab Dispos 38: 1371-1380.
20. Ebert B, Seidel A, Lampen A, (2005). Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists. Carcinogenesis 26: 1754-1763. (Pubitemid 41487991)
21. Engel T, Kannenberg F, Fobker M, Nofer J-R, Bode G, Lueken A, et al,. (2007). Expression of ATP binding cassette-transporter ABCG1 prevents cell death by transporting cytotoxic 7beta-hydroxycholesterol. FEBS Lett 581: 1673-1680. (Pubitemid 46528932)
22. Freeman LA, Kennedy A, Wu J, Bark S, Remaley AT, Santamarina-Fojo S, et al,. (2004). The orphan nuclear receptor LRH-1 activates the ABCG5/ABCG8 intergenic promoter. J Lipid Res 45: 1197-1206. (Pubitemid 38802623)
23. Furuyama S, Uehara Y, Zhang B, Baba Y, Abe S, Iwamoto T, et al,. (2009). Genotypic effect of ABCG1 gene promoter -257T>G polymorphism on coronary artery disease severity in Japanese men. J Atheroscler Thromb 16: 194-200.
24. Gelissen IC, Harris M, Rye KA, Quinn C, Brown AJ, Kockx M, et al,. (2006). ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler Thromb Vasc Biol 26: 534-540.
25. Gelissen IC, Cartland S, Brown AJ, Sandoval C, Kim M, Dinnes DL, et al,. (2010). Expression and stability of two isoforms of ABCG1 in human vascular cells. Atherosclerosis 208: 75-82.
26. Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, Chu X, et al,. (2010). Membrane transporters in drug development. Nat Rev Drug Discov 9: 215-236.
27. Graf GA, Li WP, Gerard RD, Gelissen I, White A, Cohen JC, et al,. (2002). Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface. J Clin Invest 110: 659-669. (Pubitemid 34988790)
28. Graf GA, Yu L, Li WP, Gerard R, Tuma PL, Cohen JC, et al,. (2003). ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion. J Biol Chem 278: 48275-48282. (Pubitemid 37523283)
29. Graf GA, Cohen JC, Hobbs HH, (2004). Missense mutations in ABCG5 and ABCG8 disrupt heterodimerization and trafficking. J Biol Chem 279: 24881-24888. (Pubitemid 38725357)
30. Grunhage F, Acalovschi M, Tirziu S, Walier M, Wienker TF, Ciocan A, et al,. (2007). Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol. Hepatology 46: 793-801. (Pubitemid 47436126)
31. Gutmann H, Hruz P, Zimmermann C, Beglinger C, Drewe J, (2005). Distribution of breast cancer resistance protein (BCRP/ABCG2) mRNA expression along the human GI tract. Biochem Pharmacol 70: 695-699. (Pubitemid 41058704)
32. Hegedus C, Ozvegy-Laczka C, Apati A, Magocsi M, Nemet K, Orfi L, et al,. (2009). Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties. Br J Pharmacol 158: 1153-1164.
33. Henriksen U, Fog JU, Litman T, Gether U, (2005). Identification of intra- and intermolecular disulfide bridges in the multidrug resistance transporter ABCG2. J Biol Chem 280: 36926-36934. (Pubitemid 41587775)
34. Huls M, Brown CD, Windass AS, Sayer R, van den Heuvel JJ, Heemskerk S, et al,. (2008). The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane. Kidney Int 73: 220-225.
35. Ismair MG, Hausler S, Stuermer CA, Guyot C, Meier PJ, Roth J, et al,. (2009). ABC-transporters are localized in caveolin-1-positive and reggie-1-negative and reggie-2-negative microdomains of the canalicular membrane in rat hepatocytes. Hepatology 49: 1673-1682.
36. Janvilisri T, Venter H, Shahi S, Reuter G, Balakrishnan L, van Veen HW, (2003). Sterol transport by the human breast cancer resistance protein (ABCG2) expressed in Lactococcus lactis. J Biol Chem 278: 20645-20651. (Pubitemid 36806364)
37. Johnson BJ, Lee JY, Pickert A, Urbatsch IL, (2010). Bile acids stimulate ATP hydrolysis in the purified cholesterol transporter ABCG5/G8. Biochemistry 49: 3403-3411.
38. Kennedy MA, Barrera GC, Nakamura K, Baldán A, Tarr PT, Fishbein MC, et al,. (2005). ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metabolism 1: 121-131. (Pubitemid 43977167)
39. Kerr ID, Jones PM, George AM, (2010). Multidrug efflux pumps: the structures of prokaryotic ATP-binding cassette transporter efflux pumps and implications for our understanding of eukaryotic P-glycoproteins and homologues. FEBS J 277: 550-563.
40. Kim JE, Singh RR, Cho-Vega JH, Drakos E, Davuluri Y, Khokhar FA, et al,. (2009). Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B-cell lymphoma. Mod Pathol 22: 1312-1320.
41. Klett EL, Lee MH, Adams DB, Chavin KD, Patel SB, (2004). Localization of ABCG5 and ABCG8 proteins in human liver, gall bladder and intestine. BMC Gastroenterol 4: 21.
42. Klucken J, Buchler C, Orso E, Kaminski WE, Porsch-Ozcurumez M, Liebisch G, et al,. (2000). ABCG1(ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. PNAS 97: 817-822. (Pubitemid 30070393)
43. Kobayashi A, Takanezawa Y, Hirata T, Shimizu Y, Misasa K, Kiora N, et al,. (2006). Efflux of sphingomyelin, cholesterol and phosphatidylcholine by ABCG1. J Lipid Res 47: 1791-1802. (Pubitemid 44222830)
44. Krishnamurthy P, Ross DD, Nakanishi T, Bailey-Dell K, Zhou S, Mercer KE, et al,. (2004). The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J Biol Chem 279: 24218-24225. (Pubitemid 38725283)
45. Kuo KK, Shin SJ, Chen ZC, Yang YH, Yang JF, Hsiao PJ, (2008). Significant association of ABCG5 604Q and ABCG8 D19H polymorphisms with gallstone disease. Br J Surg 95: 1005-1011.
46. Kuppens IE, Witteveen EO, Jewell RC, Radema SA, Paul EM, Mangum SG, et al,. (2007). A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients. Clin Cancer Res 13: 3276-3285. (Pubitemid 46944913)
47. Langheim S, Yu L, von Bergmann K, Lutjohann D, Xu F, Hobbs HH, et al,. (2005). ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bile. J Lipid Res 46: 1732-1738. (Pubitemid 41099340)
48. Lee MH, Lu K, Hazard S, Yu H, Shulenin S, Hidaka H, et al,. (2001). Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 27: 79-83. (Pubitemid 32044523)
49. Li AC, Binder CJ, Gutierrez A, Brown KK, Plotkin CR, Pattison JW, et al,. (2004). Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. J Clin Invest 114: 1564-1576. (Pubitemid 40385547)
50. Liao R, Sun J, Zhang L, Lou G, Chen M, Zhou D, et al,. (2008). MicroRNAs play a role in the development of human hematopoietic stem cells. J Cell Biochem 104: 805-817. (Pubitemid 351830831)
51. Lorkowski S, Rust S, Engel T, Jung E, Tegelkamp K, Galinski EA, et al,. (2001). Genomic sequence and structure of the human ABCG1 (ABC8) gene. Biochem Biophys Res Commun 280: 121-131. (Pubitemid 32917486)
52. McDevitt CA, Collins RF, Conway M, Modok S, Storm J, Kerr ID, et al,. (2006). Purification and 3D structural analysis of oligomeric human multidrug transporter ABCG2. Structure 14: 1623-1632. (Pubitemid 46107268)
53. McDevitt CA, Crowley E, Hobbs G, Starr KJ, Kerr ID, Callaghan R, (2008). Is ATP binding responsible for initiating drug translocation by the multidrug transporter ABCG2? FEBS J 275: 4354-4362.
54. Maliepaard M, Scheffer GL, Faneyte IF, van Gastelen MA, Pijnenborg AC, Schinkel AH, et al,. (2001a). Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 61: 3458-3464. (Pubitemid 32695041)
55. Maliepaard M, van Gastelen MA, Tohgo A, Hausheer FH, van Waardenburg RC, de Jong LA, et al,. (2001b). Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918. Clin Cancer Res 7: 935-941. (Pubitemid 32708732)
56. Matsuura F, Wang N, Chen W, Jiang XC, Tall AR, (2006). HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway. J Clin Invest 116: 1435-1442.
57. Merino G, Alvarez AI, Pulido MM, Molina AJ, Schinkel AH, Prieto JG, (2006). Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion. Drug Metab Dispos 34: 690-695.
58. Nagelin MH, Srinivasan S, Nadler JL, Hedrick CC, (2009). Murine 12/15 lipoxygenase regulates ATP-binding cassette transporter G1 protein degradation through p38- and JNK2-dependent pathways. J Biol Chem 284: 31303-31314.
59. Nakanishi T, Bailey-Dell KJ, Hassel BA, Shiozawa K, Sullivan DM, Turner J, et al,. (2006). Novel 5′ untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues: implications for drug resistance, tissue-specific expression, and alternative promoter usage. Cancer Res 66: 5007-5011. (Pubitemid 43844920)
60. Out R, Hoekstra M, Meurs I, deVos P, Kuiper J, Van Eck M, et al,. (2007). Total body ABCG1 expression protects against early atherosclerotic lesion development in mice. Arterioscler Thromb Vasc Biol 27: 594-599.
61. Out R, Hoekstra M, Habets K, Meurs I, de Waard V, Hildebrand RB, et al,. (2008). Combined deletion of macrophage ABCA1 and ABCG1 leads to massive lipid accumulation in tissue macrophages and distinct atherosclerosis at relatively low plasma cholesterol levels. Arterioscler Thromb Vasc Biol 28: 258-264. (Pubitemid 351161197)
62. Ozvegy-Laczka C, Hegedus T, Varady G, Ujhelly O, Schuetz JD, Varadi A, et al,. (2004). High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter. Mol Pharmacol 65: 1485-1495. (Pubitemid 38668306)
63. Pan YZ, Morris ME, Yu AM, (2009). MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells. Mol Pharmacol 75: 1374-1379.
64. Pawar A, Botolin D, Mangelsdorf DJ, Jump DB, (2003). The role of liver X receptor-alpha in the fatty acid regulation of hepatic gene expression. J Biol Chem 278: 40736-40743. (Pubitemid 37280889)
65. Pawarode A, Shukla S, Minderman H, Fricke SM, Pinder EM, O'Loughlin KL, et al,. (2007). Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins. Cancer Chemother Pharmacol 60: 179-188. (Pubitemid 46742532)
66. Rabindran SK, Ross DD, Doyle LA, Yang W, Greenberger LM, (2000). Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. Cancer Res 60: 47-50. (Pubitemid 30058728)
67. Rayner KJ, Suarez Y, Davalos A, Parathath S, Fitzgerald ML, Tamehiro N, et al,. (2010). miR-33 contributes to the regulation of cholesterol homeostasis. Science 328: 1570-1573.
68. Repa JJ, Berge KE, Pomajzl C, Richardson JA, Hobbs H, Mangelsdorf DJ, (2002). Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem 277: 18793-18800. (Pubitemid 34952438)
69. Rosenberg MF, Bikadi Z, Chan J, Liu X, Ni Z, Cai X, et al,. (2010). The human breast cancer resistance protein (BCRP/ABCG2) shows conformational changes with mitoxantrone. Structure 18: 482-493.
70. Sabol SL, Brewer HB, Santamarina-Fojo S, (2005). The human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver. J Lipid Res 46: 2151-2167. (Pubitemid 41377467)
71. Salen G, Kwiterovich PO, Jr, Shefer S, Tint GS, Horak I, Shore V, et al,. (1985). Increased plasma cholestanol and 5 alpha-saturated plant sterol derivatives in subjects with sitosterolemia and xanthomatosis. J Lipid Res 26: 203-209. (Pubitemid 15078100)
72. Salen G, von Bergmann K, Lutjohann D, Kwiterovich P, Kane J, Patel SB, et al,. (2004). Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia. Circulation 109: 966-971. (Pubitemid 38282848)
73. Savary S, Denizot F, Luciani M-F, Mattei M-G, Chimini G, (1996). Molecular cloning of a mammalian ABC transporter homologous to Drosophila white gene. Mamm Genome 7: 673-676. (Pubitemid 126443504)
74. Schou F, Frikke-Schmidt R, Nordestgaard BG, Kardassis D, Thymiakou E, Jensen G, et al,. (2008). Functional mutation in ABCG1 predicts risk of ischemic heart disease in the general population. Circulation 118: S471.
75. Shaw JA, Bobik A, Murphy A, Kanellakis P, Blombery P, Mukhamedova N, et al,. (2008). Infusion of reconstituted high-density lipoprotein leds to acute changes in human atherosclerotic plaque. Circ Res 103: 1084-1091.
76. Shukla S, Robey RW, Bates SE, Ambudkar SV, (2006). The calcium channel blockers, 1,4-dihydropyridines, are substrates of the multidrug resistance-linked ABC drug transporter, ABCG2. Biochemistry 45: 8940-8951. (Pubitemid 44100690)
77. Sparreboom A, Loos WJ, Burger H, Sissung TM, Verweij J, Figg WD, et al,. (2005). Effect of ABCG2 genotype on the oral bioavailability of topotecan. Cancer Biol Ther 4: 650-658.
78. Sumi K, Tanaka T, Uchida A, Magoori K, Urashima Y, Ohashi R, et al,. (2007). Cooperative interaction between hepatocyte nuclear factor 4 alpha and GATA transcription factors regulates ATP-binding cassette sterol transporters ABCG5 and ABCG8. Mol Cell Biol 27: 4248-4260. (Pubitemid 46906550)
79. Szatmari I, Vamosi G, Brazda P, Balint BL, Benko S, Szeles L, et al,. (2006). Peroxisome proliferator-activated receptor gamma-regulated ABCG2 expression confers cytoprotection to human dendritic cells. J Biol Chem 281: 23812-23823. (Pubitemid 44274157)
80. Tamura A, Wakabayashi K, Onishi Y, Takeda M, Ikegami Y, Sawada S, et al,. (2007). Re-evaluation and functional classification of non-synonymous single nucleotide polymorphisms of the human ATP-binding cassette transporter ABCG2. Cancer Sci 98: 231-239. (Pubitemid 44941876)
81. Tardif JC, Gregoire J, L'Allier PL, Ibrahim R, Lesperance J, Heinonen TM, et al,. (2007). Effects of reconsituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. JAMA 297: 1675-1682. (Pubitemid 46631626)
82. Tarling EJ, Bojanic DD, Tangirala RK, Wang X, Lovgren-Sandblom A, Lusis AJ, et al,. (2010). Impaired development of atherosclerosis in Abcg1-/- Apoe-/- mice: identification of specific oxysterols that both accumulate in ABCG1-/- ApoE-/- tissues and induce apoptosis. Arterioscler Thromb Vasc Biol 30: 1174-1180.
83. Tarr P, Edwards PA, (2008). ABCG1 and ABCG4 are co-expressed in neurons and astrocytes of the CNS and regulate cholesterol homeostasis trough SREBP-2. J Lipid Res 49: 169-182.
84. Terasaka N, Wang N, Yvan-Charvet L, Tall AR, (2007). High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1. PNAS 104: 15093-15098. (Pubitemid 47619598)
85. Thomassen MJ, Barna BP, Malur AG, Bonfield TL, Farver CF, Malur A, et al,. (2007). ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis. J Lipid Res 48: 2762-2768. (Pubitemid 350272860)
86. To KK, Robey RW, Knutsen T, Zhan Z, Ried T, Bates SE, (2009). Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2. Mol Cancer Ther 8: 2959-2968.
87. Turner JG, Gump JL, Zhang C, Cook JM, Marchion D, Hazlehurst L, et al,. (2006). ABCG2 expression, function, and promoter methylation in human multiple myeloma. Blood 108: 3881-3889. (Pubitemid 44864572)
88. Vaughan AS, Oram JF, (2006). ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL. J Lipid Res 47: 2433-2443. (Pubitemid 44936105)
89. Velamakanni S, Janvilisri T, Shahi S, van Veen HW, (2008). A functional steroid-binding element in an ATP-binding cassette multidrug transporter. Mol Pharmacol 73: 12-17. (Pubitemid 350294192)
90. Venkateswaran A, Repa JJ, Lobaccaro JM, Bronson A, Mangelsdorf DJ, Edwards PA, (2000). Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols. J Biol Chem 275: 14700-14707. (Pubitemid 30339762)
91. Visvader JE, Lindeman GJ, (2008). Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-768.
92. Vlaming ML, Lagas JS, Schinkel AH, (2009). Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice. Adv Drug Deliv Rev 61: 14-25.
93. Volk EL, Schneider E, (2003). Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter. Cancer Res 63: 5538-5543. (Pubitemid 37139875)
94. Vrins C, Vink E, Vandenberghe KE, Frijters R, Seppen J, Groen AK, (2007). The sterol transporting heterodimer ABCG5/ABCG8 requires bile salts to mediate cholesterol efflux. FEBS Lett 581: 4616-4620. (Pubitemid 47418786)
95. Wang J, Sun F, Zhang DW, Ma Y, Xu F, Belani JD, et al,. (2006a). Sterol transfer by ABCG5 and ABCG8: in vitro assay and reconstitution. J Biol Chem 281: 27894-27904. (Pubitemid 44414501)
96. Wang N, Ranalletta M, Matsuura F, Peng F, Tall AR, (2006b). LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL. Arterioscler Thromb Vasc Biol 26: 1310-1316. (Pubitemid 44305375)
97. Wang N, Yvan-Charvet L, Lutjohann D, Mulder M, Vanmierlo T, Kim T-W, et al,. (2008). ATP-binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate sterol accumulation in the brain. FASEB J 22: 1073-1082. (Pubitemid 351519962)
98. Wang XQ, Ongkeko WM, Chen L, Yang ZF, Lu P, Chen KK, et al,. (2010). Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway. Hepatology 52: 528-539.
99. Weiss J, Rose J, Storch CH, Ketabi-Kiyanvash N, Sauer A, Haefeli WE, et al,. (2007). Modulation of human BCRP (ABCG2) activity by anti-HIV drugs. J Antimicrob Chemother 59: 238-245. (Pubitemid 47072063)
100. Weiss J, Sauer A, Divac N, Herzog M, Schwedhelm E, Boger RH, et al,. (2010). Interaction of angiotensin receptor type 1 blockers with ATP-binding cassette transporters. Biopharm Drug Dispos 31: 150-161.
101. Whetzel AM, Sturek JM, Nagelin MH, Bolick DT, Gebre AK, Parks JS, et al,. (2010). ABCG1 deficiency in mice promotes endothelial activation and monocyte-endothelial interactions. Arterioscler Thromb Vasc Biol 30: 809-817.
102. Woodward OM, Kottgen A, Coresh J, Boerwinkle E, Guggino WB, Kottgen M, (2009). Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci USA 106: 10338-10342.
103. Xie Y, Xu K, Linn DE, Yang X, Guo Z, Shimelis H, et al,. (2008). The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells. J Biol Chem 283: 3349-3356.
104. Xu J, Liu Y, Yang Y, Bates S, Zhang JT, (2004). Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2. J Biol Chem 279: 19781-19789. (Pubitemid 38623417)
105. Yu L, von Bergmann K, Lutjohann D, Hobbs HH, Cohen JC, (2005). Ezetimibe normalizes metabolic defects in mice lacking ABCG5 and ABCG8. J Lipid Res 46: 1739-1744. (Pubitemid 41099341)
106. Yvan-Charvet L, Ranalletta M, Wang N, Han S, Terasaka N, Li R, et al,. (2007). Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J Clin Invest 117: 3900-3908. (Pubitemid 350224099)
107. Zhang W, Mojsilovic-Petrovic J, Andrade MF, Zhang H, Ball M, Stanimirovic DB, (2003). Expression and functional characterization of ABCG2 in brain endothelial cells and vessels. FASEB J 17: 2085-2087.
108. Zhang Y, Gupta A, Wang H, Zhou L, Vethanayagam RR, Unadkat JD, et al,. (2005). BCRP transports dipyridamole and is inhibited by calcium channel blockers. Pharm Res 22: 2023-2034. (Pubitemid 41821581)